Skip to main content
. Author manuscript; available in PMC: 2021 Oct 11.
Published in final edited form as: J Neurooncol. 2020 Oct 11;149(3):437–445. doi: 10.1007/s11060-020-03627-0

Table 3:

DLT by Dose Level

Dose Level Evaluable patients (n) No. patients with DLT DLT
32 mg/m2/d 3 0
52 mg/m2/d 3 0
88 mg/m2/d 8 2 Prolonged neutropenia (n = 1) Prolonged thrombocytopenia (n = 1)
116 mg/m2/d 12 2 Hemolysis (Gr 3), thrombocytopenia (Gr 4) (n = 1)
Thrombocytopenia, Gr 4 (n=l)